3 Jays prospects suspended in MLB drug investigation

Five minor league pitchers,including three in the Blue Jays' system, have been suspended for drug violations.

Minor-league pitchers Juan Jimenez, Naswell Paulino, Jol Concepcion tested positive for Boldenone

Pitcher Travis Eckert, centre, with ball, is one of five minor-league baseball players suspended for using performance-enhancing drugs. (Smiley N. Pool/Associated Press)

Five minor league pitchers,including three in the Blue Jays' system, have been suspended for drug violations.

The commissioner's office announced the penalties Tuesday.

Jays prospects Juan Jimenez and Naswell Paulino were each suspended for 72 games, and Jol Concepcion was banned for 60 games. Jimenez, Paulino and Concepcion tested for Boldenone, a performance-enhancing substance.

Jimenez and Paulino are on the roster for the rookie-level Dominican Summer League Blue Jays, and Concepcion is on the roster of the rookie-level Gulf Coast League Blue Jays.

Kansas City minor leaguer Travis Eckert and free-agent lefty Kevin Duchene each tested positive for a drug of abuse. Eckert was suspended for 50 games following a second positive test, and Duchene received a 100-game penalty following a third positive test.

Eckert is on the roster for Single-A Lexington of the South Atlantic League.

There have been 79 suspensions under the minor league drug program this year and five under the major league program.


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversation  Create account

Already have an account?